Chief

Apsida Life Science; España; A distancia; EUR 10.000 - 30.000; A tiempo parcial

Descripción de la vacante

A biotechnology company is seeking a Fractional Chief Medical Officer with extensive experience in pulmonology. This role involves leading the clinical strategy and development roadmap while collaborating with scientific and regulatory teams. The ideal candidate will have a solid background in clinical program design and successful experience in biotech environments. Competitive consulting compensation is offered.

Servicios

Competitive consulting compensation

Potential for equity participation

Formación

• 10+ years of experience in biotech/pharma clinical development.
• Prior involvement in regulatory interactions and IND-enabling activities.
• Experience working in startup or resource-constrained environments.

Responsabilidades

• Develop and maintain clinical development roadmap.
• Lead identification of CROs and clinical trial sites.
• Support investor pitches and strategic partnership discussions.

Conocimientos

Clinical strategy development

Pulmonology expertise

Phase I/II program design

Excellent communication skills

Educación

MD or MD/PhD with board certification in Pulmonology

Descripción del empleo

Recruitment Manager - Clinical & Medical Hiring - Contracts

Title: Fractional Chief Medical Officer (Pulmonology Background)

Location: Remote, with periodic on-site or travel as needed

Engagement: Part-Time / Fractional (Consulting)

About the Company: We are an early‑stage, seed‑funded biotechnology company focused on advancing a novel therapeutic platform to address unmet needs in pulmonary and inflammatory diseases. As we progress through preclinical development, we are seeking a Fractional Chief Medical Officer (CMO) to guide our translational strategy and prepare the organization for first‑in‑human clinical studies within the next 12–18 months. This is a high‑impact role that will work closely with scientific leadership, advisors, and investors.

Position Overview: The Fractional CMO will serve as the lead medical and clinical strategist for the company. The ideal candidate will bring deep expertise in pulmonology and translational/early clinical development, with the ability to shape clinical strategy, define our PhaseI/II pathway, support fundraising, and help build clinical partnerships. This individual will be instrumental in translating scientific innovation into a clear and credible clinical plan that advances the company toward regulatory submissions and early clinical trials.

Key Responsibilities

• Clinical Strategy & Development
• Develop and maintain the overall clinical development roadmap, with emphasis on first‑in‑human and early proof‑of‑concept strategies.
• Identify target patient populations, trial endpoints, and potential clinical indications with alignment to commercial and scientific priorities.
• Evaluate and guide biomarker strategy, including translational assays, sample collection planning, and clinical relevance.
• Support the design of PhaseI clinical study protocols, including dose selection rationale and safety monitoring plans.
• Collaborate with regulatory consultants to prepare documentation for pre‑IND meetings and IND filings.
• Translational Medicine Leadership
• Integrate preclinical data into clinically meaningful hypotheses and development milestones.
• Provide medical insight to guide target selection, dose prediction, and pharmacology studies.
• Ensure scientific and medical rationales are clearly articulated in internal and external communications.
• Clinical Trial Planning & Execution
• Lead identification and selection of CROs, clinical trial sites, investigators, and scientific advisors.
• Establish relationships with key opinion leaders (KOLs) in pulmonology and related therapeutic areas.
• Advise on patient recruitment strategy, feasibility assessments, and trial operational planning.
• Support investor pitches, diligence requests, and strategic partnership discussions.
• Represent the company at scientific conferences, advisory boards, and partnering meetings.
• Provide clear medical and strategic narratives that communicate the clinical rationale and competitive differentiation.

Qualifications

• MD or MD/PhD with board certification in Pulmonology (or related pulmonary medicine specialty).
• 10+ years of experience in biotech/pharma clinical development, including hands‑on experience with PhaseI/II program design.
• Prior involvement in regulatory interactions and IND‑enabling activities.
• Proven ability to translate preclinical findings into clinical strategy.
• Experience working in startup or resource‑constrained environments; comfort working in a small, dynamic team.
• Excellent communication skills: able to convey complex scientific concepts to scientific, clinical, and investor audiences.
• Previous fractional/consulting CMO experience is a plus but not required.

Engagement Structure

• Fractional / part‑time role, average of ~20–40 hours per month depending on company needs and candidate flexibility.
• Competitive consulting compensation with potential for equity participation.